Found 1 articles for: "Dupilumab 2017 to 2019"

Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019

October 2022 | Volume 21 | Issue 10 | Editorials | 1138 | Copyright © October 2022

Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, ho...
Read More